My Current Use of Biologic Approaches for Tissue Repair

Description

The presentation titled "My Current Use of Biologic Approaches for Tissue Repair" was delivered by Scott Rodeo, a sports medicine practitioner and clinician scientist from the Hospital for Special Surgery in New York City. Rodeo discussed the potential of regenerative medicine therapies in treating soft tissue injuries, particularly focusing on orthobiologics.



He began by emphasizing the promise of these techniques, whilst cautioning that they are not yet fully ready for mainstream clinical application. He uses these biological materials judiciously, mentioning various types of blood-based formulations like PRP (Platelet-Rich Plasma) and cell therapies. He noted that while animal studies show promise for these interventions, there are distinct limitations and concerns about the unregulated use of unproven therapies leading to potential setbacks in the medical field.



Rodeo provided insights into the current landscape of cell therapies, acknowledging their potential but also highlighting significant unknowns and the need for further development in this area. He discussed the importance of correct terminology in cell therapy, proposing that "connective tissue progenitor" is a more accurate descriptor than "stem cells" for the current techniques used in treatments.



The presentation included data from various studies, particularly focusing on the effectiveness of PRP in managing symptoms of knee osteoarthritis (OA), revealing that leukocyte-poor formulations appear beneficial in providing pain relief and functional improvement. However, he noted a lack of data supporting structural modifications of tissues due to these therapies.



Rodeo also touched on the use of biologics in specific soft tissue repairs like rotator cuff and meniscus tears, mentioning how current evidence is mixed regarding the benefits of PRP and cell therapies. He concluded that while biologic materials could modify symptoms, more significant research is needed to substantiate their effectiveness in structural healing.



Overall, Rodeo's presentation highlighted the need for cautious optimism in the use of biologics for tissue repair, acknowledging both current capabilities and the ongoing challenges facing the field.

Specialties